- Home
- Companies
- APR Medtech Ltd
- Products
- Transit-Pelletsmethod
Transit-Pelletsmethod
SINGLE X-RAY METHOD THAT CAN DISTINGUISH BETWEEN NORMAL AND DELAYED CTT IN BOTH MEN AND WOMEN. Clinically, the Transit-Pellets method is suitable to use in patients presenting with symptoms where a transit disturbance may be of pathophysiological and clinical importance, including chronic constipation and chronic diarrhoea. The severity of the transit problem is quantifiable by the transit test and the result may be an important variable; it may facilitate the decision on further diagnostic procedures, it effects the choice of therapy and long-term prognosis. Segmental and total colonic transit time is calculated according to the distribution of the markers in the different segments of the bowel. The transit time is equal to the total number of retained markers divided by the daily dose, which results in a colonic transit time value that is compared with normal values.
- Measure rapid, normal and slow colonic transit 1, 2
- Differentiate between slow transit and normal transit constipation 3, 4, 5
- Identify segmental colon dysfunction in patients with constipation 3
- Differentiate between normal and rapid transit diarrhoea 6, 4
- Identify treatment effects in patients with chronic constipation 7
The device is for a chronic or severe state, where the initial treatment has not resolved the abdominal discomfort, such as:
- In patients with chronic constipation and used to aid in differentiating slow and normal constipation
- In patients with chronic diarrhoea to determine if the dysfunction is linked to abnormally rapid or to normal transit rate
- In patients with Irritable Bowel Syndrome (IBS) with troublesome constipation or troublesome diarrhoea
- Product fully CE marked
- Encapsulated pre-cut radiopaque markers packed for single patient use
- Vegetarian capsules
- Easy to administer
- Manufactured in Sweden
- FDA 510(k) Class II clearance for US-market
The device is prescribed by a physician for the patient to administer the device at home. The device is taken in a transparent HPMC capsule and passes through the mouth, throat and gastrointestinal tract. It is not surgically invasive.
On day seven, the patient undergoes an X-ray examination or fluoroscopy in a clinic. Based on the number of retained markers and their position a colonic transit time is calculated and compared to reference values.